DK201100161U3 - Formuleringer med polyethylenglycol og mannitol - Google Patents

Formuleringer med polyethylenglycol og mannitol Download PDF

Info

Publication number
DK201100161U3
DK201100161U3 DKBA201100161U DKBA201100161U DK201100161U3 DK 201100161 U3 DK201100161 U3 DK 201100161U3 DK BA201100161 U DKBA201100161 U DK BA201100161U DK BA201100161 U DKBA201100161 U DK BA201100161U DK 201100161 U3 DK201100161 U3 DK 201100161U3
Authority
DK
Denmark
Prior art keywords
peg
weight
solid
formulation
formulations
Prior art date
Application number
DKBA201100161U
Other languages
Danish (da)
English (en)
Inventor
Stein Peter
Cox Ian
Smith Samuel
Jones Leighton
Plessl Joerg
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1018648.4A external-priority patent/GB201018648D0/en
Priority claimed from DE202010016235U external-priority patent/DE202010016235U1/de
Priority claimed from AU2011100528A external-priority patent/AU2011100528B4/en
Application filed by Norgine Bv filed Critical Norgine Bv
Application granted granted Critical
Publication of DK201100161U3 publication Critical patent/DK201100161U3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DKBA201100161U 2010-11-04 2011-11-04 Formuleringer med polyethylenglycol og mannitol DK201100161U3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1018648.4A GB201018648D0 (en) 2010-11-04 2010-11-04 Formulations
DE202010016235U DE202010016235U1 (de) 2010-12-06 2010-12-06 Formulierungen
AU2011100528A AU2011100528B4 (en) 2011-05-10 2011-05-10 Formulations

Publications (1)

Publication Number Publication Date
DK201100161U3 true DK201100161U3 (da) 2012-02-24

Family

ID=45689078

Family Applications (1)

Application Number Title Priority Date Filing Date
DKBA201100161U DK201100161U3 (da) 2010-11-04 2011-11-04 Formuleringer med polyethylenglycol og mannitol

Country Status (5)

Country Link
AT (1) AT12928U1 (fr)
DK (1) DK201100161U3 (fr)
FI (1) FI9608U1 (fr)
FR (1) FR2967069B3 (fr)
IE (1) IES20110480A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3056109B1 (fr) * 2016-09-21 2019-10-11 Pierre Fabre Medicament Utilisation de formulations solides de polyethylene glycol dans le traitement de la constipation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004758A1 (fr) * 1997-07-25 1999-02-04 Elan Corporation Plc Procede de preparation de granules servant a produire des comprimes solubles dans la bouche a desintegration rapide
US7256202B2 (en) * 2003-12-31 2007-08-14 Halow George M Composition and method for treatment of hepatic encephalopathy
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
JP5276435B2 (ja) * 2005-05-06 2013-08-28 セイリックス ファーマシューティカルズ, インコーポレイティッド ポリエチレングリコールの結腸の下剤組成物
WO2007057924A1 (fr) * 2005-11-21 2007-05-24 Panacea Biotec Ltd Composition laxative a base de triphala

Also Published As

Publication number Publication date
FI9608U1 (fi) 2012-03-29
FR2967069B3 (fr) 2012-11-16
IES20110480A2 (en) 2012-07-18
FR2967069A3 (fr) 2012-05-11
AT12928U1 (de) 2013-02-15

Similar Documents

Publication Publication Date Title
CN103282021A (zh) 炎症性疾病
JPWO2006054710A1 (ja) 最大消化管通過時間改善剤、消化管通過時間改善剤及び大腸癌予防剤
DK201100161U3 (da) Formuleringer med polyethylenglycol og mannitol
KR20200016608A (ko) 체중조절용 건강식품 조성물
EP2387408A1 (fr) Composition nutritionnelle énergétique comprenant un laxatif, des électrolytes et des taux de glucides
JPWO2008053984A1 (ja) アロエおよび寒天を含有した健康食品
Astley et al. The small intestine pattern in normal children and in coeliac disease: its relationship to the nature of the opaque medium
JP2017190298A (ja) 体内で水素を産生する組成物、及びサプリメント
JP6270362B2 (ja) 関節痛改善剤
WO2014185283A1 (fr) Agent et procédé de traitement utilisables à des fins d'examen ou de chirurgie de l'intestin
JP5279946B1 (ja) 関節痛改善剤
EP1884241A1 (fr) Preparation orale comprenant du chlorhydrate de dyclonine
CN111655250A (zh) 伤害感受性疼痛的预防或改善用组合物
Parwe et al. Effect of Panchalavan churna with goghruta in malavstambha (constipation)
US11298373B1 (en) Bowel cleansing chemical composition and associated use therefore
JP5872534B2 (ja) 腸内環境改善剤
US20220249542A1 (en) Bowel cleansing chemical composition and associated use therefore
KR101842041B1 (ko) 하제 조성물
RU2358740C1 (ru) Способ подготовки к колоноскопическому исследованию детей разных возрастных групп
JP2010100576A (ja) 便秘改善剤
Sainani et al. Manual of Clinical & Practical Medicine
Prouty et al. Duodenal compression by the mesenteric artery
AU2011100528A4 (en) Formulations
CN103990150B (zh) 一种用于钡餐造影检查的产气胶囊及其制备方法
El Fortia et al. Olibanum bezoar: complication of a traditional popular medicine

Legal Events

Date Code Title Description
UUP Utility model expired

Expiry date: 20211104